These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
560 related items for PubMed ID: 9187691
1. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker. Darson MF, Pacelli A, Roche P, Rittenhouse HG, Wolfert RL, Young CY, Klee GG, Tindall DJ, Bostwick DG. Urology; 1997 Jun; 49(6):857-62. PubMed ID: 9187691 [Abstract] [Full Text] [Related]
2. Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases. Darson MF, Pacelli A, Roche P, Rittenhouse HG, Wolfert RL, Saeid MS, Young CY, Klee GG, Tindall DJ, Bostwick DG. Urology; 1999 May; 53(5):939-44. PubMed ID: 10223487 [Abstract] [Full Text] [Related]
3. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Bostwick DG, Pacelli A, Blute M, Roche P, Murphy GP. Cancer; 1998 Jun 01; 82(11):2256-61. PubMed ID: 9610707 [Abstract] [Full Text] [Related]
7. Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia. Marchal C, Redondo M, Padilla M, Caballero J, Rodrigo I, García J, Quian J, Boswick DG. Histol Histopathol; 2004 Jul 01; 19(3):715-8. PubMed ID: 15168332 [Abstract] [Full Text] [Related]
8. In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL. Kwiatkowski MK, Recker F, Piironen T, Pettersson K, Otto T, Wernli M, Tscholl R. Urology; 1998 Sep 01; 52(3):360-5. PubMed ID: 9730444 [Abstract] [Full Text] [Related]
9. Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases. Bostwick DG, Qian J, Maihle NJ. Prostate; 2004 Feb 01; 58(2):164-8. PubMed ID: 14716741 [Abstract] [Full Text] [Related]
10. Time-resolved fluorescence imaging for specific and quantitative immunodetection of human kallikrein 2 and prostate-specific antigen in prostatic tissue sections. Siivola P, Pettersson K, Piironen T, Lövgren T, Lilja H, Bjartell A. Urology; 2000 Oct 01; 56(4):682-8. PubMed ID: 11018639 [Abstract] [Full Text] [Related]
11. Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands. Abrahamsson PA, Lilja H, Falkmer S, Wadström LB. Prostate; 1988 Oct 01; 12(1):39-46. PubMed ID: 2450341 [Abstract] [Full Text] [Related]
12. Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen. Recker F, Kwiatkowski MK, Piironen T, Pettersson K, Huber A, Lümmen G, Tscholl R. Urology; 2000 Apr 01; 55(4):481-5. PubMed ID: 10736487 [Abstract] [Full Text] [Related]
13. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity. Finlay JA, Evans CL, Day JR, Payne JK, Mikolajczyk SD, Millar LS, Kuus-Reichel K, Wolfert RL, Rittenhouse HG. Urology; 1998 May 01; 51(5):804-9. PubMed ID: 9610595 [Abstract] [Full Text] [Related]
14. Glycoprotein A-80 in the human prostate: immunolocalization in prostatic intraepithelial neoplasia, carcinoma, radiation failure, and after neoadjuvant hormonal therapy. Coogan CL, Bostwick DG, Bloom KJ, Gould VE. Urology; 2003 Jan 01; 61(1):248-52. PubMed ID: 12559317 [Abstract] [Full Text] [Related]
15. Immunoreactivity for prostate-specific antigen and prostatic acid phosphatase in adenocarcinoma of the prostate: relation to progression following radical prostatectomy. Sauvageot J, Epstein JI. Prostate; 1998 Jan 01; 34(1):29-33. PubMed ID: 9428385 [Abstract] [Full Text] [Related]
16. Changes in immunohistochemical staining of PSA, PAP, and TURP-27 following irradiation therapy for clinically localized prostate cancer. Grob BM, Schellhammer PF, Brassil DN, Wright GL. Urology; 1994 Oct 01; 44(4):525-9. PubMed ID: 7524238 [Abstract] [Full Text] [Related]
17. Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Rittenhouse HG, Finlay JA, Mikolajczyk SD, Partin AW. Crit Rev Clin Lab Sci; 1998 Aug 01; 35(4):275-368. PubMed ID: 9759557 [Abstract] [Full Text] [Related]
18. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate. Tamboli P, Amin MB, Xu HJ, Linden MD. Mod Pathol; 1998 Mar 01; 11(3):247-52. PubMed ID: 9521470 [Abstract] [Full Text] [Related]
19. Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate. Tennant MK, Thrasher JB, Twomey PA, Birnbaum RS, Plymate SR. J Clin Endocrinol Metab; 1996 Jan 01; 81(1):411-20. PubMed ID: 8550786 [Abstract] [Full Text] [Related]